A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias. [electronic resource]
Producer: 20100914Description: 1437-44 p. digitalISSN:- 1476-5551
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacokinetics
- Benzenesulfonates -- pharmacokinetics
- Extracellular Signal-Regulated MAP Kinases -- antagonists & inhibitors
- Female
- Humans
- Leukemia, Myeloid, Acute -- blood
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- blood
- Protein Kinase Inhibitors -- pharmacokinetics
- Pyridines -- pharmacokinetics
- Recurrence
- Sorafenib
- fms-Like Tyrosine Kinase 3 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.